Abstract

PurposeTo evaluate the potential of the texture features extracted from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) intratumoral subregions to distinguish benign from malignant breast tumors.Materials and MethodsA total of 299 patients with pathologically verified breast tumors who underwent breast DCE-MRI examination were enrolled in this study, including 124 benign cases and 175 malignant cases. The whole tumor area was semi-automatically segmented on the basis of subtraction images of DCE-MRI in Matlab 2018b. According to the time to peak of the contrast agent, the whole tumor area was partitioned into three subregions: early, moderate, and late. A total of 467 texture features were extracted from the whole tumor area and the three subregions, respectively. Patients were divided into training (n = 209) and validation (n = 90) cohorts by different MRI scanners. The least absolute shrinkage and selection operator (LASSO) method was used to select the optimal feature subset in the training cohort. The Kolmogorov-Smirnov test was first performed on texture features selected by LASSO to test whether the samples followed a normal distribution. Two machine learning methods, decision tree (DT) and support vector machine (SVM), were used to establish classification models with a 10-fold cross-validation method. The performance of the classification models was evaluated with receiver operating characteristic (ROC) curves.ResultsIn the training cohort, the areas under the ROC curve (AUCs) for the DT_Whole model and SVM_Whole model were 0.744 and 0.806, respectively. In contrast, the AUCs of the DT_Early model (P = 0.004), DT_Late model (P = 0.015), SVM_Early model (P = 0.002), and SVM_Late model (P = 0.002) were significantly higher: 0.863 (95% CI, 0.808–0.906), 0.860 (95% CI, 0.806–0.904), 0.934 (95% CI, 0.891–0.963), and 0.921 (95% CI, 0.876–0.954), respectively. The SVM_Early model and SVM_Late model achieved better performance than the DT_Early model and DT_Late model (P = 0.003, 0.034, 0.008, and 0.026, respectively). In the validation cohort, the AUCs for the DT_Whole model and SVM_Whole model were 0.670 and 0.708, respectively. In comparison, the AUCs of the DT_Early model (P = 0.006), DT_Late model (P = 0.043), SVM_Early model (P = 0.001), and SVM_Late model (P = 0.007) were significantly higher: 0.839 (95% CI, 0.747–0.908), 0.784 (95% CI, 0.601–0.798), 0.890 (95% CI, 0.806–0.946), and 0.865 (95% CI, 0.777–0.928), respectively.ConclusionThe texture features from intratumoral subregions of breast DCE-MRI showed potential in identifying benign and malignant breast tumors.

Highlights

  • Breast cancer is one of the most common cancers and the main cause of cancer deaths in women, accounting for approximately 30% of new cancer cases in women and 14% of cancer deaths [1]

  • The area under the ROC curve (AUC) of the DT_Early model (P = 0.006), DT_Late model (P = 0.043), SVM_Early model (P = 0.001), and SVM_Late model (P = 0.007) were significantly higher: 0.839, Radiomics on Breast DCE-Magnetic resonance imaging (MRI)

  • The texture features from intratumoral subregions of breast dynamic contrast-enhanced MRI (DCE-MRI) showed potential in identifying benign and malignant breast tumors

Read more

Summary

Introduction

Breast cancer is one of the most common cancers and the main cause of cancer deaths in women, accounting for approximately 30% of new cancer cases in women and 14% of cancer deaths [1]. The treatment options for benign and malignant breast tumors differ, as do the local recurrence and survival rates [4]. Benign breast tumors are generally curable through active treatment, whereas malignant tumors are difficult to cure and usually require surgery after neoadjuvant therapy to suppress local recurrence [5,6,7]. Among the available MRI methods, dynamic contrast-enhanced MRI (DCE-MRI) can provide tumor anatomical information and hemodynamic information with high spatial resolution, and it plays an important role in the diagnosis, differential diagnosis, and treatment response assessment of breast cancer [10,11,12,13]. The rate of preoperative breast DCE-MRI examinations is increasing, and an effective method for characterizing enhanced lesions is crucial to improve the accuracy of diagnosis

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call